| Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan SE Girardin, IG Boneca, LAM Carneiro, A Antignac, M Jehanno, J Viala, ... Science 300 (5625), 1584-1587, 2003 | 1970 | 2003 |
| Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries … AB Brueggemann, MJJ van Rensburg, D Shaw, ND McCarthy, KA Jolley, ... The Lancet Digital Health 3 (6), e360-e370, 2021 | 417 | 2021 |
| Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment U Vogel, MK Taha, JA Vazquez, J Findlow, H Claus, P Stefanelli, ... The Lancet infectious diseases 13 (5), 416-425, 2013 | 358 | 2013 |
| Serogroup W135 meningococcal disease in Hajj pilgrims MK Taha, M Achtman, JM Alonso, B Greenwood, M Ramsay, A Fox, ... The Lancet 356 (9248), 2159, 2000 | 337 | 2000 |
| Simultaneous Approach for Nonculture PCR-Based Identification and Serogroup Prediction of Neisseria meningitidis MK Taha Journal of clinical microbiology 38 (2), 855-857, 2000 | 329 | 2000 |
| Meningococcal meningitis: unprecedented incidence of serogroup X—related cases in 2006 in Niger P Boisier, P Nicolas, S Djibo, MK Taha, I Jeanne, HB Maínassara, ... Clinical Infectious Diseases 44 (5), 657-663, 2007 | 316 | 2007 |
| Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex LW Mayer, MW Reeves, N Al-Hamdan, CT Sacchi, MK Taha, GW Ajello, ... Journal of Infectious Diseases 185 (11), 1596-1605, 2002 | 294 | 2002 |
| Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? R Cohen, M Ashman, MK Taha, E Varon, F Angoulvant, C Levy, A Rybak, ... Infectious diseases now 51 (5), 418-423, 2021 | 287 | 2021 |
| The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection R Borrow, P Alarcón, J Carlos, DA Caugant, H Christensen, R Debbag, ... Expert review of vaccines 16 (4), 313-328, 2017 | 285 | 2017 |
| Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage J Lucidarme, DMC Hill, HB Bratcher, SJ Gray, M Du Plessis, RSW Tsang, ... Journal of Infection 71 (5), 544-552, 2015 | 245 | 2015 |
| Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup B Neisseria meningitidis E Murphy, L Andrew, KL Lee, DA Dilts, L Nunez, PS Fink, K Ambrose, ... Journal of Infectious Diseases 200 (3), 379-389, 2009 | 242 | 2009 |
| Down‐regulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein AE Deghmane, D Giorgini, M Larribe, JM Alonso, MK Taha Molecular microbiology 43 (6), 1555-1564, 2002 | 213 | 2002 |
| Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing IP Châtelet, Y Traore, BD Gessner, A Antignac, B Naccro, ... Clinical infectious diseases 40 (1), 17-25, 2005 | 210 | 2005 |
| The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004–2014 R Whittaker, JG Dias, M Ramliden, C Ködmön, A Economopoulou, N Beer, ... Vaccine 35 (16), 2034-2041, 2017 | 204 | 2017 |
| The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high … R Acevedo, X Bai, R Borrow, DA Caugant, J Carlos, M Ceyhan, ... Expert review of vaccines 18 (1), 15-30, 2019 | 192 | 2019 |
| The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease LH Harrison, SI Pelton, A Wilder-Smith, J Holst, MAP Safadi, JA Vazquez, ... Vaccine 29 (18), 3363-3371, 2011 | 160 | 2011 |
| Correlations between carbon metabolism and virulence in bacteria S Poncet, E Milohanic, A Mazé, JN Abdallah, F Aké, M Larribe, ... Bacterial Sensing and Signaling 16, 88-102, 2009 | 148 | 2009 |
| Interaction of Neisseria meningitidis with the Components of the Blood-Brain Barrier Correlates with an Increased Expression of PilC B Pron, MK Taha, C Rambaud, JC Fournet, N Pattey, JP Monnet, ... Journal of Infectious Diseases 176 (5), 1285-1292, 1997 | 146 | 1997 |
| The Role of Particular Strains of Neisseria meningitidis in Meningococcal Arthritis, Pericarditis, and Pneumonia P Vienne, M Ducos-Galand, A Guiyoule, R Pires, D Giorgini, MK Taha, ... Clinical infectious diseases 37 (12), 1639-1642, 2003 | 137 | 2003 |
| Target Gene Sequencing To Characterize the Penicillin G Susceptibility of Neisseria meningitidis MK Taha, JA Vázquez, E Hong, DE Bennett, S Bertrand, S Bukovski, ... Antimicrobial agents and chemotherapy 51 (8), 2784-2792, 2007 | 136 | 2007 |
